Fingerprint
Dive into the research topics of 'Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials
A. Blauvelt*, K. Reich, K. A. Papp, A. B. Kimball, M. Gooderham, S. K. Tyring, R. Sinclair, D. Thaçi, Q. Li, N. Cichanowitz, S. Green, C. La Rosa
*Corresponding author for this work
22
Citations
(Scopus)